AKASA

Product Operations & QA Specialist

AKASA
Apply
2 months ago
San Francisco, CA, USA or New York, NY, USAMid Level
H1B Sponsor

Base Salary

$60k - $85k/yr

Responsibilities

  • Own end-to-end testing and support for one or more product areas.
  • Design, maintain, and improve testing plans, regression suites, and QA checklists.
  • Help define go/no-go criteria for releases in partnership with PM/TPM/eng.
  • Own tier-one and triage workflows for their product area.
  • Triage and route complex or high-impact issues to the right stakeholders.
  • Monitor and report on key support metrics for their product area.

Requirements

  • Minimum 2 years of experience in a healthcare setting (hospital or clinic) required.
  • Strong ability to prioritize testing and support work based on risk and impact.
  • Communicates patterns and insights in a structured, persuasive way.
  • Anticipates issues and proactively updates content and processes.
  • Familiarity with regression and feature testing frameworks.
  • Proven ability to manage goals and deadlines effectively.
  • Can work independently in a remote/virtual work environment.

Benefits

  • Flexible paid time off (PTO).
  • Expansive coverage for health, dental, and vision.
  • Employer contribution to Health Savings Accounts (HSA).
  • Generous parental leave policy.
  • Full employee coverage for life insurance.
  • Home office stipend.
  • Cell phone/internet reimbursement.
  • Company-paid holidays.
  • 401(K) plan.

Categories

AKASA

About AKASA

51-200 employees

AKASA is rapidly becoming the GenAI partner of choice for leading health systems, with recent national recognition of our Cleveland Clinic deployment as “one of the most comprehensive real-world uses of GenAI in healthcare finance to date.” Across customers, AKASA now delivers an average of $3.1M in additional revenue and 4,270 additional quality indicators per 10,000 discharges, demonstrating consistent, measurable impact. Our advantage comes from building a custom LLM for each health system, capturing their clinical nuance to drive superior accuracy across the mid-cycle — spanning prior authorization, CDI, inpatient coding, and clinical denials appeals. This approach allows organizations to modernize critical workflows and unlock material improvements in both revenue and quality. With investors including Andreessen Horowitz, BOND, Costanoa Ventures, and others, we’ve raised more than $200M to help eliminate the financial complexity of healthcare. We’re rebuilding the revenue cycle with AI. Let’s chat.

Contact me